Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 50018488
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196377(5-[4-(4-bromo-phenylamino)-phenylamino]-3-hydroxy-...)
Affinity DataIC50: 87nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196371(5-[4-(4-bromo-phenylamino)-phenylamino]-3-hydroxy-...)
Affinity DataIC50: 140nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196373(5-[4-(4-bromo-phenylamino)-phenylamino]-3-hydroxy-...)
Affinity DataIC50: 220nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196382(5-[4-(4-bromo-phenylamino)-phenylamino]-N-cyclohex...)
Affinity DataIC50: 300nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196374(5-[4-(4-bromo-phenylamino)-phenylamino]-3-hydroxy-...)
Affinity DataIC50: 310nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196390(3-hydroxy-N-isopropyl-5-(4-phenylamino-phenylamino...)
Affinity DataIC50: 420nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196393(5-[4-(4-bromo-phenylamino)-phenylamino]-3-hydroxy-...)
Affinity DataIC50: 460nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196392(3-hydroxy-N-1-hydroxypropan-2-yl)-5-4-phenylamino)...)
Affinity DataIC50: 460nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196383(5-[4-(4-bromo-phenylamino)-phenylamino]-N-(2,3-dih...)
Affinity DataIC50: 470nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196378(N-(2,3-dihydroxy-propyl)-3-hydroxy-5-(4-phenylamin...)
Affinity DataIC50: 900nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196369(3-hydroxy-N-(2-hydroxy-ethyl)-5-(4-phenylamino-phe...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196385(3-hydroxy-N-(4-hydroxy-butyl)-5-(4-phenylamino-phe...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196372(N-cyclohexylmethyl-3-hydroxy-5-(4-phenylamino-phen...)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196387(3-hydroxy-N-isopropyl-5-(4-phenoxy-phenylamino)-is...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196389(5-(4-benzoyl-phenylamino)-N-cyclohexylmethyl-3-hyd...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196370(5-(4-benzyl-phenylamino)-3-hydroxy-N-isopropyl-iso...)
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196381(3-hydroxy-N-isopropyl-5-(4-phenylazo-phenylamino)-...)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196388(N-cyclohexylmethyl-3-hydroxy-5-(4-phenylazo-phenyl...)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196384(N-(2,3-dihydroxy-propyl)-3-hydroxy-5-[4-(4-propyl-...)
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196380(N-cyclohexylmethyl-3-hydroxy-5-(4-phenylsulfanyl-p...)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196391(5-(4-cyclohexyl-phenylamino)-3-hydroxy-N-isopropyl...)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196386(5-(4-benzyl-phenylamino)-N-cyclohexylmethyl-3-hydr...)
Affinity DataIC50: 3.70E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196379(5-(4-benzenesulfonyl-phenylamino)-3-hydroxy-N-isop...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196376(3-hydroxy-N-(2-hydroxy-1-methyl-ethyl)-5-(4-pyrazo...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Valeant Pharmaceutical Research and Development 3300 Hyland Avenue

Curated by ChEMBL
LigandPNGBDBM50196375(N-cyclohexylmethyl-3-hydroxy-5-(4-pyrazol-1-yl-phe...)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of Chk2 kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed